Results 31 to 40 of about 113,909 (286)
Quality of life with ivabradine in patients with angina pectoris [PDF]
, 2016 Background—To explore the effect of ivabradine on angina-related quality of life (QoL) in patients participating in the Study Assessing the Morbidity–Mortality Benefits of the If Inhibitor Ivabradine in Patients with Coronary Artery Disease (SIGNIFY) QoL
Chassany, Olivier +6 more
core +1 more source
Bladder Pheochromocytoma Presented as Thunderclap Headache Triggered by Urination and Angina Pectoris [PDF]
Kosin Medical Journal, 2013 Pheochromocytoma is a catecholamine-producing tumor characterized by hypertension, headache, tachycardia, excessive diaphoresis, and angina pectoris. The thunderclap headache is so named because the pain strikes suddenly and severely.
You Jin Han +5 more
doaj +1 more source
IMMUNO-INFLAMATORY RESPONSE IN ISCHEMIC HEART DISEASE
Рациональная фармакотерапия в кардиологии, 2015 Aim. To estimate the role of immuno-inflammatory response in developing of angina pectoris in patients with ischemic heart disease (IHD).Material and methods: The study included 83 patients with IHD and angina pectoris of functional class (FC) II (30 ...
N. E. Zakirova +4 more
doaj +3 more sources
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve. [PDF]
, 2015 AimsThe mechanistic basis of the symptoms and signs of myocardial ischaemia in patients without obstructive coronary artery disease (CAD) and evidence of coronary microvascular dysfunction (CMD) is unclear.
Anderson, R David +15 more
core +1 more source
Journal of Cardiovascular Development and Disease, 2023 Coronary sinus reducer (CSR) implantation is a new treatment option for patients with refractory angina pectoris. However, there is no evidence from a randomized trial that would show an improvement in exercise capacity after this treatment.
Miha Mrak +4 more
doaj +1 more source
Efficacy profile of ivabradine in patients with heart failure plus angina pectoris [PDF]
, 2016 Objectives: In the Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial (SHIFT), slowing of the heart rate with ivabradine reduced cardiovascular death or heart failure hospitalizations among patients with systolic chronic heart ...
Borer, Jeffrey S. +9 more
core +1 more source
Assessment of physical Domain for patients with angina pectoris
Kufa Journal for Nursing Sciences, 2012 Objective: To assess the physical domain for patients with angina pectoris. Methodology: A descriptive study was carried out, in March 15th 2012 to June 15th 2012, to assess physical domain for patients with angina pectoris. A purposive sample of (50)
Wissam jabbar kassim
doaj +1 more source